-
Enterprise Plenary Session III
Sofia Venceslau (Ph.D.)Done
-
Oral Session II A
Rita CarapitoDone
-
Oral Session III C
Carina PeresDone
-
Plenary Session II
Roland Bücker (Ph.D.)Done
-
Closing Session
Done
-
Coffee Break
Done
-
Hot Topics II: New biomolecules: Challenges in the development and clinical translation
Carlos Neto, PharmD: Medical Scientific Liaison at Angelini Pharma Portugal and Pedro Madureira, Co-founder and CSO at IMMUNETHEPDone
-
Poster Session II (w/ Refreshment Break)
Done
-
Flash Session I (D)
Natanael FernandesDone
-
Oral Session I B
Diana PereiraDone
Lunch Break
13/02/2023, 13:00
-
13/02/2023, 14:20
(UTC)
(1 hour 20 minutes)
